This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.
SPEAKERS
Dan Stanton
CEO, BioProcess Insider
Harsh Chauhan
Head of Science, Creighton University
Jenny Chauhan
Head of Science, Creighton University
Harsh Chauhan
Professor, PHD, Auvergne University
Dan Stanton
CEO, BioProcess Insider
DISCUSSION POINTS
- Lorem ipsum dolor sit amet
- Lorem ipsum dolor sit amet
- Lorem ipsum dolor sit amet
- Lorem ipsum dolor sit amet
- Lorem ipsum dolor sit amet
- Lorem ipsum dolor sit amet
TALK SPONSOR
